CD371-YSNVZIL-18 CAR T Cells

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD371-YSNVZIL-18 CAR T Cells, covering 2026-02-19 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia [Phase 1]